Dynamic Technology Lab Private Ltd Has $1.16 Million Holdings in Trupanion, Inc. (NASDAQ:TRUP)

Dynamic Technology Lab Private Ltd raised its stake in Trupanion, Inc. (NASDAQ:TRUP) by 108.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 24,022 shares of the financial services provider’s stock after buying an additional 12,474 shares during the period. Dynamic Technology Lab Private Ltd’s holdings in Trupanion were worth $1,158,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wells Fargo & Company MN raised its stake in Trupanion by 44.1% during the 4th quarter. Wells Fargo & Company MN now owns 15,798 shares of the financial services provider’s stock worth $761,000 after buying an additional 4,836 shares during the period. Trexquant Investment LP raised its position in shares of Trupanion by 229.3% during the fourth quarter. Trexquant Investment LP now owns 138,109 shares of the financial services provider’s stock worth $6,657,000 after purchasing an additional 96,174 shares during the period. Pictet Asset Management Holding SA acquired a new stake in shares of Trupanion during the fourth quarter worth about $242,000. New Age Alpha Advisors LLC bought a new position in shares of Trupanion during the 4th quarter valued at about $1,819,000. Finally, JPMorgan Chase & Co. grew its position in shares of Trupanion by 458.3% in the 4th quarter. JPMorgan Chase & Co. now owns 158,099 shares of the financial services provider’s stock valued at $7,620,000 after purchasing an additional 129,782 shares during the period.

Trupanion Trading Down 1.9 %

NASDAQ:TRUP opened at $34.34 on Friday. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90. The company has a market cap of $1.46 billion, a P/E ratio of -149.30, a price-to-earnings-growth ratio of 6.02 and a beta of 1.70. The business has a 50 day moving average price of $39.64 and a two-hundred day moving average price of $46.19.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The business had revenue of $337.31 million for the quarter, compared to analyst estimates of $335.41 million. As a group, analysts expect that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Insider Transactions at Trupanion

In related news, SVP Emily Dreyer sold 14,025 shares of the company’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $32.41, for a total transaction of $454,550.25. Following the sale, the senior vice president now owns 27,645 shares in the company, valued at approximately $895,974.45. This represents a 33.66 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Margaret Tooth sold 4,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $37.17, for a total value of $148,680.00. Following the completion of the transaction, the chief executive officer now owns 118,784 shares of the company’s stock, valued at approximately $4,415,201.28. This represents a 3.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 29,792 shares of company stock worth $989,442 in the last three months. Insiders own 5.50% of the company’s stock.

Analysts Set New Price Targets

Several analysts have commented on TRUP shares. Piper Sandler dropped their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Stifel Nicolaus cut their price objective on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $46.60.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.